Scientific Program

Conference Series Ltd invites all the participants across the globe to attend International Conference on Diabetes and Cholesterol Metabolism Dubai, UAE.

Day 2 :

Keynote Forum

Amr Alfakhouri

Lusatian Lakeland Klinikum GmbH, Germany

Keynote: Ablation strategies for atrial fibrillation
Conference Series Metabolic Diseases 2019 International Conference Keynote Speaker Amr Alfakhouri photo
Biography:

Amr Alfakhouri, after qualifying as an Internist in Syria in 2011, he continued with his residencies in Germany and then became a specialist in Internal Medicine and Cardiology in 2017. He has gained experience in the field of Cardiac Electrophysiology and Device Therapy at the Heart and Vascular Day Hospital Dresden (Praxisklinik Herz und Gefäße Dresden), the Heart Centre Dresden and Heart Centre Cottbus. Currently he is employed as a Consultant Interventional Cardiologist and Electrophysiologist at Lausitzer Seenland Klinikum in Hoyerswerda, Germany. He also participated in the global research “CABANA and RDN-AF Enlight” at the Heart Centre Dresden.

Abstract:

Atrial fibrillation (AF) is the most common sustained arrhythmia. Recent guidelines recommend pulmonary vein isolation (PVI) as the main procedural endpoint to control recurrent AF in symptomatic patients resistant to antiarrhythmic drugs. The efficacy of such a procedure is still unsatisfactory in persistent AF. Thus, the search is on-going in trying to find adjunctive strategies that can fortify the durability of ablation success in AF patients. This review summarizes the benefits of AF ablation techniques, discusses the evidence underlying different approaches other than PVI including: linear ablation, ablation of complex fractionated atrial electro grams (CFAE), focal impulse and rotor modulation (FIRM), ablation guided by spatiotemporal electro gram dispersion, repetitive activation patterns (RAPs) and other sites frequently involved in AF triggers. It is interesting that other independent randomized studies (for example SMAN-AF and STAR AF II trails) have failed to reproduce the same successful results. The reason for the lack of benefit associated with additional ablation in these trials is unclear. A possible explanation is that more extensive ablation may cause new, iatrogenic areas of arrhythmogenesis. It is noted that the low success rate occurred even though the rate of acute procedural AF termination during CFAE ablation was high.

Conclusion: Future studies need to focus on new ablation strategies to achieve better results.

  • Insulin and Beta Cell Targeting | Balanced Diet and Chronic Diseases | Pharmaceutical Diabetes Treatments and Diagnosis | Current Research in Cardiology | Lipid Metabolism and Diabetes | Type 2 Diabetes and Its Treatments

Session Introduction

Emran Dawoud

The Wellness Center, Kuwait

Title: Integrative nutrition and chronic diseases

Time :

Speaker
Biography:

Emran Dawoud completed his Ph.D. in Health Physics which is part of the Nuclear Engineering Department from the University of Tennessee, Knoxville. Started his career at Oak Ridge National Laboraory, Oak Ridge, TN and Kuwait Institute for Scientific Research. Also filled several faculty positions at different schools in the US, Kuwait and Jordan. Five years ago, his wife was diagnosed with triple negative Invasive Ductal Carcinoma. In his journey looking for answers to the root causes of cancer, earned an Integrative Nutrition diploma from the Institute for Integrative Nutrition, New York and became an activist promoting life style changes to overcome common chronic diseases like obesity, diabetes, hypertension, cardiovascular diseases, cognitive diseases and autoimmune diseases.

Abstract:

Wellness is a health program based on integrative nutrition, which is a comprehensive nutrition program that integrates dietary needs with lifestyle variables including physical activity, relationships, spiritual practices, and career. It promotes the idea of connecting the health of the body, mind and soul. In the past decade there has been a growing epidemic of obesity and diabetes worldwide and this has been attributed to several factors, such as poor dietary habits and sedentary lifestyles. The aim of our program is to tackle this epidemic. Dietary changes are the first line of treatment for type 2 diabetes. These changes usually revolve around reducing sugar intake; however studies have shown that a more detailed dietary plan is required to enhance the sensitivity to insulin. Varying degrees of carbohydrate intake affect the metabolic process. For example, a low-carb diet requires the release of insulin to metabolize glucose through the mTOR signalling pathway, while in a ketogenic diet, the depletion of glycogen stores results in the release of insulin through the AMPK pathway. Dietary plans are based on caloric intake and/or the constituent macronutrients; those two factors affect the metabolic activity of an individual, but are not the sole contributors. The concept of integrative nutrition assesses the impact of other factors on the metabolic process. Metabolism occurs through a chain of chemical reactions during which different enzymes and hormones are released. This process is affected by the previously mentioned life style variables. A recent study showed that chronic stress causes massive release of glutamate which acts on certain neuro-receptors, resulting in the activation of a specific enzyme that prevents cell adhesion causing cognitive impairment. An integrative approach to dietary plans and lifestyle changes offers patients a practical tool to gain control over their obesity and diabetes. Our main goal with Wellness is to combat this epidemic and guide clients on their journey to a healthier life. In my integrative nutrition practice as a counsellor, several diabetic clients managed to control their sugar and reduce it to acceptable limits within the six months duration of the program. They also managed to control their hypertension and consequently reduce their weight, thereby improving their overall health.

Abubakar Hilal

Shaikh Zayed Hospital, Pakistan

Title: Pacemaker lead displacement
Speaker
Biography:

Abubakar Hilal has a special interest in Interventional cardiology which is one of the main clinical specialty and pillar of cardiology. He believes in building strong team environment and fostering open communications. He wishes to follow a career in teaching & research in cardiology and work in an Institute to help in developing essential clinical skills required for future under graduate & post graduate cardiology students. He is capable in his critical appraisal skills when evaluating information in the cardiology literature.

Abstract:

Pacemaker lead displacement or dislodgement is one of uncommon cause of pacemaker malfunction. It occurs due to unintentional or deliberate manipulation of the pacemaker pulse generator in the skin pocket by the patient. This leads to lead coiling, dislodgement and pacemaker failure. Elderly people mostly female, psychiatric patients and large pocket size mostly present with this problem. Mostly occurs in first year of pacemaker implantation. CXR is the diagnostic modality. Pacemaker lead repositioning is the treatment along with proper suture fixation of the lead and pulse generator within its pocket.

Speaker
Biography:

Geetendra Singh Dhanawat is an eminent diabetologist (Mumbai, India), completed his PG from CMC Vellore in Family medicine & MPH from Global University. He is fellow of Royal society of Public health & Completed his Fellowship in intensive care medicine from Apollo Hospital. He has special interest in diabetes and disease prevention. He completed PG Diabetology from John Hopkins University school of Medicine & Dip. Diabetes from Stonebridge University, UK. He is a Consultant Diabetologist. He has published several papers in reputed journals including Journal of WAO (World Allergy Organization). Member of Research society for study of Diabetes in India RSSDI.

Abstract:

India is home to over 60 million adults with diabetes (7.8% of the population), of which more than 30 million are undiagnosed or untreated, thus increasing the risk of developing complications and premature mortality. Given the challenges in early detection and management of diabetes, it is imperative to seek innovative ways that help to expand the reach of health literacy and services among the general population and high risk groups, while also improving management and quality of life in confirmed diabetics. In September 2019, we planned & conducted a survey at pan India level through various medical colleges OPD. This survey is conducted in 63 medical colleges with the help of first year & second year MBBS students. We planned a short survey and responses taken into Google survey sheet. Total 4725 candidates participated in survey & the selection of these candidates was random. The survey outcome is - Some very popular diabetes related myth taken into consideration:

• People with diabetes cannot lead a normal life – Yes (79%); No (18%) No idea (3%)
• Diabetes is more common in Men – Yes (56%); No (31%) No idea (13%)
• Testing urine sugar alone is sufficient for diagnosing diabetes – Yes (9%); No (61%) No idea (30%)
• People with diabetes should not donate blood – Yes (88%); No (4%) No idea (8%)
• Diabetes can be cured – Yes (59%); No (28%) No idea (13%)
• All types of diabetes are same – Yes (39%); No (28%) No idea (33%)
• Diabetes does not develop after 60 years – Yes (27%); No (21%) No idea (52%)
• People with Type 1 diabetes have short span of life – Yes (89%); No (8%) No idea (3%)
• People with diabetes should not travel – Yes (45%); No (51%) No idea (4%) • Drugs for diabetes should never be withdrawn – Yes (66%); No (13%) No idea (21%)
• We can relax the diet regimen when diabetes is under good control – Yes (59%); No (31%) No idea (10%)
• Fruits are to be avoided – Yes (89%); No (4%) No idea (7%)
• Consumption of sugar may cause diabetes: Yes (81%); No (9%) No idea (10%)
• Bitter fruits & Herbs can cure diabetes completely: Yes (72%); No (8%) No idea (20%)
• Some forms of yoga can cure diabetes: Yes (61%); No (19%) No idea (20%) • Insulin treatment is last resort in diabetes treatment: Yes (99%); No (1%) No idea (0%)

The survey reveals very interesting data & shows us the impact of awareness on treatment outcome. These are various misconceptions regarding diabetes in the common population. In conclusion, proper diabetes management should include a better counseling to patients and relatives & some printed form of information should also be given to the patient to circulate in his or her near vicinity to educate others. Empower the patient with right knowledge for better treatment outcome. Keep the patient in touch & ask about treatment compliance.

Speaker
Biography:

Shumoos H Alwaid has completed her Bachelor of degree in Biology from College of Sciences and MSc and PhD from Kufa University, College of Sciences. She is currently working in teaching field at The Islamic University, College of Medical Techniques.

Abstract:

Metabolic Syndrome (MetS) is a worldwide distributed public health problem and its incident in increase. MetS is characterized by clustering of several metabolic abnormalities including central (intraabdominal) obesity, dyslipidemia, hyperglycemia and hypertension. The ultimate importance of this cluster is to identify individuals at high risk of both type-2 diabetes and Cardiovascular Disease (CVD). Oxidized Low- Density Lipoprotein (Ox-LDL) which result from oxidation of LDL cholesterol is an aspect of oxidative stress. The concentration of circulating Ox-LDL has shown relationships with atherosclerotic disease, cardiovascular diseases and some studies indicate OxL-DL concentrations to be increased in the metabolic syndrome. The aim of the study is to evaluate the serum level of Ox-LDL in MetS patients regarding to metabolic syndrome risk factors, age, gender, body mass index and waist circumference. A total of the (130) participant involved in this study, blood samples had been collected from the (90) MetS patients (50 female and 40 male) and from (40) individuals who were obviously healthy as a control group. The result of the study showed a significant increase in concentration of serum Ox-LDL in MetS patients when compared with healthy group and significant differences of Ox-LDL concentration in serum among different ages groups of Mets female and males population. In regarding to BMI, the result showing significant increase Ox-LDL concentration in morbid and obese weight when compare with over weight in male MetS population. This study also indicated, there is a significant positive correlation among Ox-LDL with T. cholesterol, TG-C, LDL-C and blood sugar while negative correlation with HDL-C in all patients groups.

Speaker
Biography:

Shehzano Fakir Muhammad Kasim has completed his BDS from Jinnah Medical and Dental College, Karachi, Pakistan and MPhil from Ziauddin University, Pakistan.

Abstract:

Diabetes is a metabolic disease categorized by increase blood sugar level resulting from defects in insulin excretion, insulin function or both. The prolonged diabetes is associated with damage, dysfunction and failure of different organs especially the eyes, kidneys, nerves, heart and blood vessels. Initially diabetes was considered as a disease of western countries but its existence is virtually seen in every nation-state of world. The present prevalence in Pakistan of type-2 diabetes mellitus is 26.3%. Out of them 19.2% are known with the disease while 7.1% were newly diagnosed people. Diabetes is presently the fastest emergent epidemic disease and has been recognized to a collision between genes and the environment. Worldwide burden of disease was 382 million people in 2013 and this number will increase to 592 million by 2035. Parental history of diabetes is a chief factor for development of type-2 diabetes mellitus, but whether this association derives from shared genetic or environmental factors is unclear. Persistently high blood sugar levels can result in drastic outcomes like diabetic ketoacidosis and Hyperosmolar nonketotic syndrome. Association of gene variants and family history will help in identification of disease. Previous studies show that type-2 diabetes mellitus is associated with following genes: PPARG, TCF7L2, FTO, CDKN2A/2B, HHEX/IDE, SLC30A8, KCNQ1, JAZFI, IRSI, KLF14, CHCHD9 and DUSP9. This review highlights the role of different genes in the development of type-2 diabetes mellitus and parental history which causes the disease is a big threat to all genes that cause the disease.

Speaker
Biography:

Samra Abouchacra has had extensive clinical and academic experience in Canada and UAE. She has Canadian & American Board certification in Internal Medicine & Nephrology and Masters in Science from the Toronto Institute of Medical Sciences. She is the founder and previous chairperson for Academic Affairs department and previous chairperson of Nephrology department at Tawam Hospital. She also served as medical director of Urology Kidney Disease Service Line Council for the Emirate of Abu Dhabi and has recently held the post of Director of Outpatient Services at Tawam and now Al Ain Hospital in preparation for commissioning of the new facility. She has been actively participating in teaching and research activities with numerous publications in peer review journals and among country investigators for the International Dialysis Outcomes and Practice Patterns Study (DOPPS). She has membership in national & international medical societies and is a fellow of American Society of Nephrology.

Abstract:

Obesity has become a global epidemic, which is rapidly spreading at phenomenal rates. The gravity of this “Globesity” epidemic goes beyond sheer numbers, as it is directly linked to numerous diseases that pose serious health risks and are responsible for escalating health care expenditures. Obesity is the single most important contributor to development of type 2 diabetes along with other metabolic disorders, all of which individually increase cardiovascular morbidity and mortality. Though the solution seems straightforward with weight reduction being the best cure, however, achieving and maintaining weight loss is extremely challenging. Diets have disappointingly had limited short term benefits with lack of sustainability and even rebound weight gain. In addition to their restrictive nature, there are even more complex personal behaviour and social factors affecting food ingestion that current day “diets” do not address. This lecture will highlight these shortcomings and explore dietary behaviour patterns promoting weight gain that may be critical in sabotaging weight loss efforts. Our GERG research group has undertaken a number of research initiatives including a multicentre survey aimed at understanding eating habits in overweight and obese individuals in our region. The published data will be shared for interactive discussion. Furthermore, a recently published novel eating behaviour modification concept called “Eat-ology” will be introduced. This intervention empowers individuals to identify their own specific “Eating Errors” and imparts techniques to convert them into “Eating Essentials.” In this way, Eat-ology not only circumvents many of the shortfalls of today’s “diets,” but through non-restrictive, simple and practical principles it may enable the transformation of one’s “way of eating” to support weight loss and its long term maintenance.

Speaker
Biography:

Samra Abouchacra has had extensive clinical and academic experience in Canada and UAE. She has Canadian & American Board certification in Internal Medicine & Nephrology and Masters in Science from the Toronto Institute of Medical Sciences. She is the founder and previous chairperson for Academic Affairs department and previous chairperson of Nephrology department at Tawam Hospital. She also served as medical director of Urology Kidney Disease Service Line Council for the Emirate of Abu Dhabi and has recently held the post of Director of Outpatient Services at Tawam and now Al Ain Hospital in preparation for commissioning of the new facility. She has been actively participating in teaching and research activities with numerous publications in peer review journals and among country investigators for the International Dialysis Outcomes and Practice Patterns Study (DOPPS). She has membership in national & international medical societies and is a fellow of American Society of Nephrology.

Abstract:

Obesity has become a global epidemic, which is rapidly spreading at phenomenal rates. The gravity of this “Globesity” epidemic goes beyond sheer numbers, as it is directly linked to numerous diseases that pose serious health risks and are responsible for escalating health care expenditures. Obesity is the single most important contributor to development of type 2 diabetes along with other metabolic disorders, all of which individually increase cardiovascular morbidity and mortality. Though the solution seems straightforward with weight reduction being the best cure, however, achieving and maintaining weight loss is extremely challenging. Diets have disappointingly had limited short term benefits with lack of sustainability and even rebound weight gain. In addition to their restrictive nature, there are even more complex personal behaviour and social factors affecting food ingestion that current day “diets” do not address. This lecture will highlight these shortcomings and explore dietary behaviour patterns promoting weight gain that may be critical in sabotaging weight loss efforts. Our GERG research group has undertaken a number of research initiatives including a multicentre survey aimed at understanding eating habits in overweight and obese individuals in our region. The published data will be shared for interactive discussion. Furthermore, a recently published novel eating behaviour modification concept called “Eat-ology” will be introduced. This intervention empowers individuals to identify their own specific “Eating Errors” and imparts techniques to convert them into “Eating Essentials.” In this way, Eat-ology not only circumvents many of the shortfalls of today’s “diets,” but through non-restrictive, simple and practical principles it may enable the transformation of one’s “way of eating” to support weight loss and its long term maintenance.

Speaker
Biography:

Samra Abouchacra has had extensive clinical and academic experience in Canada and UAE. She has Canadian & American Board certification in Internal Medicine & Nephrology and Masters in Science from the Toronto Institute of Medical Sciences. She is the founder and previous chairperson for Academic Affairs department and previous chairperson of Nephrology department at Tawam Hospital. She also served as medical director of Urology Kidney Disease Service Line Council for the Emirate of Abu Dhabi and has recently held the post of Director of Outpatient Services at Tawam and now Al Ain Hospital in preparation for commissioning of the new facility. She has been actively participating in teaching and research activities with numerous publications in peer review journals and among country investigators for the International Dialysis Outcomes and Practice Patterns Study (DOPPS). She has membership in national & international medical societies and is a fellow of American Society of Nephrology.

Abstract:

Obesity has become a global epidemic, which is rapidly spreading at phenomenal rates. The gravity of this “Globesity” epidemic goes beyond sheer numbers, as it is directly linked to numerous diseases that pose serious health risks and are responsible for escalating health care expenditures. Obesity is the single most important contributor to development of type 2 diabetes along with other metabolic disorders, all of which individually increase cardiovascular morbidity and mortality. Though the solution seems straightforward with weight reduction being the best cure, however, achieving and maintaining weight loss is extremely challenging. Diets have disappointingly had limited short term benefits with lack of sustainability and even rebound weight gain. In addition to their restrictive nature, there are even more complex personal behaviour and social factors affecting food ingestion that current day “diets” do not address. This lecture will highlight these shortcomings and explore dietary behaviour patterns promoting weight gain that may be critical in sabotaging weight loss efforts. Our GERG research group has undertaken a number of research initiatives including a multicentre survey aimed at understanding eating habits in overweight and obese individuals in our region. The published data will be shared for interactive discussion. Furthermore, a recently published novel eating behaviour modification concept called “Eat-ology” will be introduced. This intervention empowers individuals to identify their own specific “Eating Errors” and imparts techniques to convert them into “Eating Essentials.” In this way, Eat-ology not only circumvents many of the shortfalls of today’s “diets,” but through non-restrictive, simple and practical principles it may enable the transformation of one’s “way of eating” to support weight loss and its long term maintenance.

  • Complication and Preventions of Diabetes | Cardiology and Digital Health | Obesity and Cardiac Health | Diabetes Management | Hyperglycemia and Hypoglycemia

Session Introduction

Geetendra Singh Dhanawat

Aditya Bharti Centre for Diabetes & Family Medicine, India

Title: Cinnamon and management of diabetes
Speaker
Biography:

Geetendra Singh Dhanawat is an eminent diabetologist (Mumbai, India), completed his PG from CMC Vellore in Family medicine & MPH from Global University. He is fellow of Royal society of Public health & Completed his Fellowship in intensive care medicine from Apollo Hospital. He has special interest in diabetes and disease prevention. He completed PG Diabetology from John Hopkins University school of Medicine & Dip. Diabetes from Stonebridge University, UK. He is a Consultant Diabetologist. He has published several papers in reputed journals including Journal of WAO (World Allergy Organization). Member of Research society for study of Diabetes in India RSSDI.

Abstract:

Insulin sensitizing effect of Cinnamon: Miracle spice In our 14 month of clinical study the commonly used Indian spice Cinnamon showed excellent results in prediabetic & newly diagnosed diabetic patients. In Our clinical study we test the blood sugar lowering and insulin-sensitizing effects of Cinnamon (Cinnamomum cassia). In our study we use 3gm of cinnamon in capsules to people with diabetes for 90 days. In 45 days improvements in both fasting blood sugar and in LDL (“bad”) cholesterol evidenced. Although some clinical trial results have been equivocal, several have shown benefits of cinnamon on glucose, lipid and insulin levels. 8-13 Studies also show cinnamon can potentiate insulin action and improve insulin resistance and glucose metabolism although the detailed biochemical mechanisms aren't completely clear. Bioactive compounds in cinnamon affect several steps in insulin signaling pathways. For example, research has shown that certain water-soluble polyphenol compounds (type A polyphenols) extracted from cinnamon may increase insulin sensitivity by inhibiting an enzyme (a tyrosine phosphatase) that inactivates insulin receptors.Other research has found that water-soluble cinnamon polyphenols increase insulin-dependent proteins (GLUT4) required for glucose uptake by adipose and muscle cells. Cinnamon extracts also may decrease proteins involved in glucose production in the liver (gluconeogenesis). In addition, cinnamon compounds have antioxidant and anti-inflammatory actions, which may play a role in reducing insulin resistance and diabetes complications. The consumption of cinnamon is associated with a statistically significant decrease in levels of fasting plasma glucose, total cholesterol, LDL-C, and triglyceride levels and an increase in HDL-C levels; however, no significant effect on hemoglobin A1C was found. The high degree of heterogeneity may limit the ability to apply these results to patient care, because the preferred dose and duration of therapy are unclear.

Speaker
Biography:

Shumoos H Alwaid has graduated with a bachelor degree of biology from College of Siences, completed her MSc at the age of 26 years from Kufa University, College of Sciences and PhD studies from Kufa University, College of Sciences too. She is teaching human physiology at The Islamic University, Collage of Medical Techniques. Her PhD thesis title was “Study the interrelation between some physiological and immunological markers with diagnostic criteria of metabolic syndrome patients”.

Abstract:

Metabolic syndrome represents as a constellation of interconnected physiological, biochemical, clinical and metabolic risk factors including hypertension, dyslipidemia, central obesity, glucose intolerance, pro-inflammatory and pro-thrombotic states which reflects an underlying insulin resistance and cardio vascular disease. Metabolic syndrome is a chronic low-grade inflammatory state starting from adipose tissue and further recruits’ immune cells such as monocyte-macrophages. Adipose tissue has been suggested to be a reservoir for inflammatory cells including monocytes which either migrate to or originate within adipose tissue and release inflammatory bio mediators such as IL-6, TNFa etc. The aim of this study is to find the correlation between inflammatory bio mediator IL-6 with the diagnostic criteria in obese metabolic syndrome patients. A total of the (130) participants were divided into three study groups: women patients group included 50 subjects, men patients group included 40 subjects the control group was 40 composed of 20 healthy women and 20 healthy men. The ages of patients and control ranged 40 to 69 years old. Each patients group was divided into subgroups according to age, BMI, WC. Lipid profile and blood sugar were measured for all subjects. The results revealed significant increase in IL-6 level in serum of MetS patients in compared with control group. While the result indicated there are no significant different in IL-6 between MetS males and females. The study results also demonstrate, there is a significant positive correlation between IL6 and TC, TG, LDL-C, BS levels in MetS patients.

Speaker
Biography:

Juliot Vinolia is a Dubai Health Authority licensed clinical dietitian and community nutritionist with over a decade experience in medical nutrition therapy. As a research scholar, she received her M.Phil and Masters in Clinical Nutrition from the University of Madras, Women’s Christian College, India. Heading the nutrition department at Medeor Hospital Dubai, she has provided personalized therapeutic nutrition care for acute and chronically ill patients. She is also an active Columnist on national newspapers, magazines and corporate newsletters creating awareness on the prevention of obestity related diseases like diabetes and cardiovascular diseases. Delivered lectures at conferences, participated on radio talks and medical camps in creating healthier communities. She is affiliated with the American Society of Parenteral and Enteral Nutrition, Indian Dietetic Association and Emirates Clinical Nutriton Society.

Abstract:

Cardiovascular disease (CVD) is a well known leading cause of mortality in Western countries, representing almost 30 % of all deaths worldwide. With the rising incidence of heart disease among global statistics, the American Heart Association and many other governmental organizations has taken it as a public health priority in preventing CVD through diet and lifestyle interventions. Apart from the probability of developing CVD from an unhealthy diet and lifestyle; CVD also coincides with multiple co-morbidities such as obesity, hypertension, dyslipidemia and diabetes which represent four of the 10 greatest risk factors for all- cause mortality worldwide. Current scientific evidence and many observational studies have reported that nutrition might be the most preventive factor of CVD death and could even reverse heart disease. Several controversial diets and foods have received significant media exposure and are mired by hype. The benefits of several trending foods and dietary patterns like the ketogenic diet and fasting diets require more study period to completely understand and nutritional science continues to evolve. The 2015 to 2020 Dietary Guidelines for Americans recommend 3 healthy eating patterns: 1) the healthy US style eating pattern; 2) the healthy Mediterranean and 3) the healthy vegetarian eating pattern. The latest guidelines emphasise on maintaining a healthy weight through a healthy dietary pattern, active lifestyle, adequate sleep and stress management. Individuals with pre-existing heart disease need individualized medical nutrition therapy taking into account diabetes, hypertension and dyslipidemia management. As medical professionals our goal is to match the intensity of preventive efforts with an individual's CVD risk and the individual's willingness and capacity to implement preventive strategies.

Speaker
Biography:

Ali Al Saeed is a senior medical student at King Faisal University in Saudi Arabia. Ali is enthusiastic and passionate about science and research. He got remarkable achievements locally including the prize of first place in the research day of college of medicine King Faisal University. Ali has ongoing research project in different topics. Ali particularly is passionate about diabetes and metabolic disorders as they are prevalent in the kingdom of Saudi Arabia. His interest in diabetes and obesity led him initiate “Anti childhood obesity community’’ in the eastern province of Saudi Arabia, which is a cooperative project between King Faisal University and the United states in Riyadh. Ali is member of many of nonprofit organization in KSA including Alber charity center, Hayat association and hereditary blood diseases and blood donations associations in Al-Hassa.

Abstract:

Diabetes mellitus has become the most common metabolic disease worldwide. The edible leaves of Red cabbage (Brassica oleracea) are taken raw in salad or in the cooked form. Therefore, it was of interest to evaluate the hypoglycemic and hypolipidemic effects of ethanolic (50%) extract of the leaves of red cabbage to blood glucose, glycated hemoglobin (HbA1c) and lipid profile in streptozotocin (STZ)-induced diabetic rats. Diabetes was induced in male Wistar rats by injecting rats with a single dose (60 mg/kg body weight) of streptozotocin. Diabetic rats showed significant elevation in serum glucose, glycated hemoglobin (HbA1c) total cholesterol (TC), and triacylglycerol (TG). Daily oral supplementation (250 mg/kg body weight) of leaves of red cabbage extract for 40 days to STZ-induced diabetic rats significantly ameliorated serum glucose (p < 001), HbA1c (p < 001), TC (p < 01), and TG (p < 01). By comparison, a standard anti-hyperglycemic drug, glibenclamide when administered at a dose of 10 mg/kg body weight, reduced blood glucose, HbA1c, TC and TGs levels. It is concluded that ethanolic extract of red cabbage reduced the blood level of glucose, HbA1c and lipids and it was more effective than glibenclamide in reducing blood glucose.

Speaker
Biography:

Sanjay Kalra, an Endocrinologist, is the proprietor of Bharti Research Institute of Diabetes & Endocrinology (BRIDE), Karnal, Haryana. His extensive professional journey of 14 years covers several stellar achievements in his field of specialty. He is instrumental in providing editorial skills to several national and international medical journals focused on Endocrinology, Diabetes, Geriatrics, Family Practice, Medical Research, Pharmacology, Hypertension and Nutrition. He is an Executive Editor of the Indian Journal of Endocrinology & Metabolism and Editor-in-Chief of the International Journal of Clinical Cases & Investigations. He is the Vice President of South Asian Federation of Endocrine Societies, since 2013.

Abstract:

Aim: To determine the long-term effect of Medical Nutrition Therapy (MNT) in adults with type 2 diabetes (T2D) and prediabetes.

Background: T2D is one of the major non-communicable diseases with increasing prevalence at a global level. Individuals with T2D are at high risk of developing cardiovascular and other life-threatening conditions. Nutrient intake imbalances in diabetics are also frequently present due to food restrictions. Therefore, the effect of MNT in diabetic and pre-diabetics is studied for 24 weeks.

Methods: This is a prospective observational study where MNT (VidavanceTM) is given for 24 weeks to 325 adult participants with T2D or prediabetes (HbA1c >6.0). Participants were either taking anti-diabetic therapies along with MNT (n=156), or MNT alone (n=158). Glucose metabolism parameters and lipid profile is assessed at baseline, 12 and 24 weeks.

Results: Total 313 participants completed the study. Statistically significant reduction in HbA1c levels is seen from baseline to 12 weeks (8.6 to 7.7; p<0.001) and 24 weeks (8.6 to 7.1: p<0.001), due to only MNT. Similar significant reduction in fasting glucose (167.4 to 119.4 mg/dL) and post-prandial glucose (232.1 to 156.2 mg/ dL) are observed at 24 weeks, due to only MNT. Significant reduction in levels of lipid profile parameters is also seen. No adverse event is observed.

Discussion: Overall, MNT is found to be efficacious in reducing hyperglycemic parameters. HbA1c is reduced by 0.9% at 12 weeks and by 1.5% at 24 weeks, due to only MNT. Significant reduction in fasting and post-prandial glucose is also seen.